These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28832946)

  • 1. Codelivery of anti-cancer agents via double-walled polymeric microparticles/injectable hydrogel: A promising approach for treatment of triple negative breast cancer.
    Davoodi P; Ng WC; Srinivasan MP; Wang CH
    Biotechnol Bioeng; 2017 Dec; 114(12):2931-2946. PubMed ID: 28832946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-Walled Microparticles-Embedded Self-Cross-Linked, Injectable, and Antibacterial Hydrogel for Controlled and Sustained Release of Chemotherapeutic Agents.
    Davoodi P; Ng WC; Yan WC; Srinivasan MP; Wang CH
    ACS Appl Mater Interfaces; 2016 Sep; 8(35):22785-800. PubMed ID: 27530316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of doxorubicin and paclitaxel from double-layered microparticles: The effects of layer thickness and dual-drug vs. single-drug loading.
    Lee WL; Guo WM; Ho VHB; Saha A; Chong HC; Tan NS; Tan EY; Loo SCJ
    Acta Biomater; 2015 Nov; 27():53-65. PubMed ID: 26340886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperthermia-mediated drug delivery induces biological effects at the tumor and molecular levels that improve cisplatin efficacy in triple negative breast cancer.
    Dunne M; Dou YN; Drake DM; Spence T; Gontijo SML; Wells PG; Allen C
    J Control Release; 2018 Jul; 282():35-45. PubMed ID: 29673642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel.
    Hu H; Lin Z; He B; Dai W; Wang X; Wang J; Zhang X; Zhang H; Zhang Q
    J Control Release; 2015 Dec; 220(Pt A):189-200. PubMed ID: 26474677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained release of PTX-incorporated nanoparticles synergized by burst release of DOX⋅HCl from thermosensitive modified PEG/PCL hydrogel to improve anti-tumor efficiency.
    Xu S; Wang W; Li X; Liu J; Dong A; Deng L
    Eur J Pharm Sci; 2014 Oct; 62():267-73. PubMed ID: 24931190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulating cancer associated fibroblasts with losartan-loaded injectable peptide hydrogel to potentiate chemotherapy in inhibiting growth and lung metastasis of triple negative breast cancer.
    Hu C; Liu X; Ran W; Meng J; Zhai Y; Zhang P; Yin Q; Yu H; Zhang Z; Li Y
    Biomaterials; 2017 Nov; 144():60-72. PubMed ID: 28823844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained Codelivery of Cisplatin and Paclitaxel via an Injectable Prodrug Hydrogel for Ovarian Cancer Treatment.
    Shen W; Chen X; Luan J; Wang D; Yu L; Ding J
    ACS Appl Mater Interfaces; 2017 Nov; 9(46):40031-40046. PubMed ID: 29131563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An injectable, thermosensitive and multicompartment hydrogel for simultaneous encapsulation and independent release of a drug cocktail as an effective combination therapy platform.
    Wang W; Song H; Zhang J; Li P; Li C; Wang C; Kong D; Zhao Q
    J Control Release; 2015 Apr; 203():57-66. PubMed ID: 25683618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic enhancement of apoptosis by coralyne and paclitaxel in combination on MDA-MB-231 a triple-negative breast cancer cell line.
    Kumari S; Mohan MG; Shailender G; Badana AK; Malla RR
    J Cell Biochem; 2019 Oct; 120(10):18104-18116. PubMed ID: 31172606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan Hydrogels for Synergistic Delivery of Chemotherapeutics to Triple Negative Breast Cancer Cells and Spheroids.
    Schneible JD; Young AT; Daniele MA; Menegatti S
    Pharm Res; 2020 Jul; 37(7):142. PubMed ID: 32661774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained release paclitaxel-loaded core-shell-structured solid lipid microparticles for intraperitoneal chemotherapy of ovarian cancer.
    Han S; Dwivedi P; Mangrio FA; Dwivedi M; Khatik R; Cohn DE; Si T; Xu RX
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):957-967. PubMed ID: 30892967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel "Carrier-Free" Nanofiber Codelivery Systems with the Synergistic Antitumor Effect of Paclitaxel and Tetrandrine through the Enhancement of Mitochondrial Apoptosis.
    Li X; Yu N; Li J; Bai J; Ding D; Tang Q; Xu H
    ACS Appl Mater Interfaces; 2020 Mar; 12(9):10096-10106. PubMed ID: 32027119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chetomin induces apoptosis in human triple-negative breast cancer cells by promoting calcium overload and mitochondrial dysfunction.
    Dewangan J; Srivastava S; Mishra S; Pandey PK; Divakar A; Rath SK
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1915-1921. PubMed ID: 29208466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer.
    Zeng F; Ju RJ; Liu L; Xie HJ; Mu LM; Zhao Y; Yan Y; Hu YJ; Wu JS; Lu WL
    Oncotarget; 2015 Nov; 6(34):36625-42. PubMed ID: 26429872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy inhibition re-sensitizes pulse stimulation-selected paclitaxel-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis.
    Wen J; Yeo S; Wang C; Chen S; Sun S; Haas MA; Tu W; Jin F; Guan JL
    Breast Cancer Res Treat; 2015 Feb; 149(3):619-29. PubMed ID: 25638397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injectable composite hydrogels embedded with gallium-based liquid metal particles for solid breast cancer treatment via chemo-photothermal combination.
    Lee W; Shin MJ; Kim S; Lee CE; Choi J; Koo HJ; Choi MJ; Kim JH; Kim K
    Acta Biomater; 2024 May; 180():140-153. PubMed ID: 38604467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced therapeutic effect of paclitaxel with a natural polysaccharide carrier for local injection in breast cancer.
    Jang H; Zhi K; Wang J; Zhao H; Li B; Yang X
    Int J Biol Macromol; 2020 Apr; 148():163-172. PubMed ID: 31935404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation of a triple combination gemcitabine plus romidepsin + cisplatin regimen to efficaciously and safely control triple-negative breast cancer tumor development.
    Pattarawat P; Wallace S; Pfisterer B; Odoi A; Wang HR
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):141-152. PubMed ID: 31865420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.